Cargando…
Neglecting Plasma Protein Binding in COVID‐19 Patients Leads to a Wrong Interpretation of Lopinavir Overexposure
Boffito et al. recalled the critical importance to correctly interpret protein binding. Changes of lopinavir pharmacokinetics in coronavirus disease 2019 (COVID‐19) are a perfect illustration. Indeed, several studies described that total lopinavir plasma concentrations were considerably higher in pa...
Autores principales: | Stanke‐Labesque, Francoise, Concordet, Didier, Djerada, Zoubir, Bouchet, Stéphane, Solas, Caroline, Mériglier, Etienne, Bonnet, Fabrice, Mourvillier, Bruno, Ruiz, Stéphanie, Martin‐Blondel, Guillaume, Epaulard, Olivier, Schwebel, Carole, Gautier‐Veyret, Elodie, Gandia, Peggy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013748/ https://www.ncbi.nlm.nih.gov/pubmed/33547636 http://dx.doi.org/10.1002/cpt.2196 |
Ejemplares similares
-
Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment
por: Stanke-Labesque, Françoise, et al.
Publicado: (2020) -
Variability of Isavuconazole Trough Concentrations during Longitudinal Therapeutic Drug Monitoring
por: Bolcato, Léa, et al.
Publicado: (2022) -
Modifications pharmacocinétiques liées à une infection aiguë. Exemples issus de la pandémie de SARS-CoV-2
por: Chavant, Anaëlle, et al.
Publicado: (2021) -
Variability of Tacrolimus Trough Concentration in Liver Transplant Patients: Which Role of Inflammation?
por: Chavant, Anaelle, et al.
Publicado: (2021) -
Tocilizumab Trough Levels Variability in Kidney-Transplant Candidates Undergoing Desensitization
por: Truffot, Aurélie, et al.
Publicado: (2021)